Koskinas, Konstantinos C.
(Switzerland)
13 papers on CoChatORCID 0000-0002-5589-7762
Most cited papers
- Verified
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal
Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches
Cited by 5,685
- Verified
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 4,854
- Verified
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal
Blood Pressure and Hypertension StudiesClinical practice guidelines implementation
Cited by 2,298
- Verified
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2021) · European Heart Journal
Cardiac pacing and defibrillation studiesCardiac Arrest and Resuscitation
Cited by 2,019
- Verified
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
Mach, F., Koskinas, K. C., Roeters van Lennep, J. E., Tokgözoğlu, L., Badimon, L., Baigent, C., Benn, M., Binder, C. J., Catapano, A. L., De Backer, G. G., et al. (2025) · European Heart Journal
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 688
- Verified · note
2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · Russian Journal of Cardiology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 325
- Verified
Obesity and cardiovascular disease: An ESC clinical consensus statement
Koskinas, K. C., Van Craenenbroeck, E. M., Antoniades, C., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Heart Journal
Cardiovascular Function and Risk FactorsObesity, Physical Activity, Diet
Cited by 313
- Verified
Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation
Fragakis, N., Koskinas, K. C., Katritsis, D. G., Pagourelias, E. D., Zografos, T., & Geleris, P. (2012) · The American Journal of Cardiology
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments
Cited by 82
- Verified
Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation
Koskinas, K. C., Fragakis, N., Katritsis, D., Skeberis, V., & Vassilikos, V. (2014) · Europace
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments
Cited by 72
- Verified
Eligibility for PCSK9 inhibitors according to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines after acute coronary syndromes
Gencer, B., Koskinas, K. C., Räber, L., Karagiannis, A., Nanchen, D., Auer, R., Carballo, D., Carballo, S., Klingenberg, R., Heg, D., et al. (2017) · Journal of the American Heart Association
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 35
- Verified
Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial
Koskinas, K. C., Windecker, S., Buhayer, A., Gencer, B., Pedrazzini, G., Mueller, C., Cook, S., Muller, O., Matter, C. M., Räber, L., et al. (2018) · Clinical Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 26
- Verified
Biomarkers Associated with Mortality in Aortic Stenosis: A Systematic Review and Meta-Analysis
White, M., Baral, R., Ryding, A., Tsampasian, V., Ravindrarajah, T., Garg, P., Koskinas, K. C., Clark, A., & Vassiliou, V. S. (2021) · Medical Sciences
Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches
Cited by 26
- Verified
Effectiveness and safety of bempedoic acid in routine clinical practice: 1-year follow-up snapshot of the MILOS German cohort
Gouni-Berthold, I., Koskinas, K., Averna, M., Stulnig, T., Vanassche, T., Blackburn, C., Smolnik, R., Soronen, J., Wenz-Poschl, K., Pinto, X., et al. (2023) · European Heart Journal
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free